HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $9 price target on the company's stock.

November 20, 2023 | 11:13 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical and maintained a $9 price target.
The reiteration of a Buy rating and the maintenance of a $9 price target by a reputable analyst could lead to increased investor confidence in DRTS, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100